Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Bendamustine Hydrochloride × Breast × Clear all

Phase

Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 51 Other hematologic neoplasm 30 Plasma cell 9 CNS 3 Tumor-Agnostic 2 Other solid neoplasm 2 Dermatologic 2 Sarcoma 1 Myeloid 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Paclitaxel 99 Trastuzumab 81 pembrolizumab 76 Cyclophosphamide 66 Fulvestrant 65 Carboplatin 47 Capecitabine 47 Docetaxel 45 palbociclib 40 Lapatinib 40 Letrozole 35 Doxorubicin 29 olaparib 28 Taxes 28 Nivolumab 25 Gemcitabine 25 130-nm albumin-bound paclitaxel 25 Magnetic Resonance Spectroscopy 24 Everolimus 23 Biopsy 22 ribociclib 21 abemaciclib 21 Albumin-Bound Paclitaxel 21 Specimen Handling 20 Radiotherapy 19 Cisplatin 19 Bevacizumab 19 Ado-Trastuzumab Emtansine 19 pertuzumab 17 Alpelisib 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00661739 2011-09-02

RiTa

GBG Forschungs GmbH

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡